glp-1 obesity drug news today september 2025 New Daily Weight Loss Pill Aims to Take on Ozempic Alarming rise in weight loss

& Rajewsky, K

Notably, completed and ongoing studies such as NCT06475586, NCT06937060, NCT06588296, and NCT06864026 are investigating semaglutide in patients with PsO and comorbid metabolic conditions, or tirzepatide (in PsA settings), assessing dermatologic outcomes and inflammatory or metabolic markers (78, 79)

Commun Biol

A clinical study found that as the intake of iron supplements increased (categorized as low, moderate, and high iron dose groups with intakes of 2.99 and 3.6 mg/4,184 kJ), the odds ratio for developing UC increased, indicating an increased disease risk with higher iron intake [273]

Other US-based online research peptide stores include Biotech Peptides, Core Peptides, and AminoVault

Listing them here identifies sources